Indobufen Versus Aspirin in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
BACKGROUND Acute ischemic stroke (AIS) is a major cause of death and disability worldwide. Early antiplatelet therapy reduces recurrence and improves outcomes. Although aspirin is standard treatment, its use is limited by bleeding risk. Indobufen, a reversible cyclooxygenase inhibitor with shorter platelet inhibition,...